Cwm, LLC Sage Therapeutics, Inc. Transaction History

Cwm, LLC

$25.1 Billion
Q1 2025

A detailed history of Cwm, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 61,416 shares of SAGE stock, worth $401,046. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,416

Previous 3,006 1943.11%

Holding current value

$401,046

Previous $16,000 2950.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	BUY	$5.55 - $8.66 $324,175 - $505,830	58,410 Added 1943.11%	61,416 $488,000
Q4 2024 Feb 04, 2025	SELL	$4.78 - $8.57 $14,598 - $26,172	-3,054 Reduced 50.4%	3,006 $16,000
Q3 2024 Oct 08, 2024	BUY	$7.02 - $13.08 $36,581 - $68,159	5,211 Added 613.78%	6,060 $44,000
Q2 2024 Jul 09, 2024	BUY	$10.58 - $17.9 $4,581 - $7,750	433 Added 104.09%	849 $9,000
Q1 2024 Apr 05, 2024	SELL	$18.62 - $26.95 $55 - $80	-3 Reduced 0.72%	416 $8,000
Q4 2023 Feb 01, 2024	SELL	$17.1 - $22.26 $13,440 - $17,496	-786 Reduced 65.23%	419 $9,000
Q3 2023 Oct 11, 2023	BUY	$16.75 - $48.98 $14,790 - $43,249	883 Added 274.22%	1,205 $25,000
Q2 2023 Aug 03, 2023	BUY	$40.65 - $59.54 $5,325 - $7,799	131 Added 68.59%	322 $15,000
Q1 2023 Apr 28, 2023	BUY	$37.27 - $46.57 $6,000 - $7,497	161 Added 536.67%	191 $8,000
Q2 2022 Jul 28, 2022	SELL	$27.52 - $37.99 $908 - $1,253	-33 Reduced 52.38%	30 $1,000
Q1 2022 Apr 21, 2022	BUY	$30.71 - $45.71 $1,504 - $2,239	49 Added 350.0%	63 $2,000
Q4 2019 Sep 14, 2021	SELL	$60.18 - $154.77 $1,263 - $3,250	-21 Reduced 60.0%	14 $1,000
Q4 2019 Jan 27, 2020	BUY	$60.18 - $154.77 $1,263 - $3,250	21 Added 150.0%	35 $3,000
Q3 2019 Sep 14, 2021	BUY	$140.29 - $189.96 $1,122 - $1,519	8 Added 133.33%	14 $1,000
Q3 2019 Oct 22, 2019	SELL	$140.29 - $189.96 $1,122 - $1,519	-8 Reduced 57.14%	6 $1,000
Q2 2019 Sep 14, 2021	BUY	$157.85 - $183.09 $1,262 - $1,464	8 Added 133.33%	14 $1,000
Q2 2019 Jul 31, 2019	SELL	$157.85 - $183.09 $1,262 - $1,464	-8 Reduced 57.14%	6 $1,000
Q1 2019 Sep 02, 2021	BUY	$89.33 - $163.65 $446 - $818	5 Added 55.56%	14 $0
Q1 2019 Apr 22, 2019	BUY	$89.33 - $163.65 $267 - $490	3 Added 50.0%	9 $1,000
Q3 2017 Oct 16, 2017	BUY	$61.4 - $88.52 $368 - $531	6	6 $0

Others Institutions Holding SAGE

# of Institutions

217

Shares Held

49.9M

Call Options Held

220K

Put Options Held

312K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $388M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account